InsidersTradesSigma
Track the 兰卫医学 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 兰卫医学 has logged 3 insider filings. Market capitalisation: €3.4bn. The latest transaction was disclosed on 26 March 2024 (Sale). Among the most active insiders: 孙林洁. Every trade is free.
3
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€3m
3 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,622 of 29,063 companies
35.1
score / 100
Value35
Quality35
FCF yld6.1%
Earn yld-0.9%
EV/EBITDA37.5x
ROE1.8%
Gross mgn24%
Net mgn-2.1%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 March 2024
关于 兰卫医学
兰卫医学是一家专注于医疗保健和制药领域的公司，为诊断和治疗提供创新解决方案。该公司在深圳证券交易所上市。